twenty-two patients with locally advanced or metastatic head and neck tumors received a total of 84 courses of a combination of cisplatin , bleomycin , and methotrexate ( pbm ) for a median of four courses per patient ( range , 1-7 ) .
C0025677
methotrexate
C0065764
pbm